If NRX-101 proves effective, then BRPA will be a winner. Globally, an estimated 46 million people in the world had bipolar disorder in 2017, with 52 and 48 percent being female and male, respectively.
Another one to look at is LGVW.
(0)
(0)
Mondobiotech Holding AG Basel (RLFTF) Stock Research Links